Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians

Launched by UNC LINEBERGER COMPREHENSIVE CANCER CENTER · Jun 27, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a new tool designed to help doctors predict the outcomes for patients with metastatic breast cancer, which is when cancer has spread to other parts of the body. The researchers want to understand how acceptable, appropriate, and easy to use this tool is for healthcare providers who work with these patients. To do this, they will conduct interviews with doctors, nurse practitioners, and other healthcare professionals who have experience caring for patients with this type of cancer. The goal is to gather feedback that will help improve the tool so that it can be effectively used in clinical settings.

To participate in this study, individuals must be healthcare providers with at least six months of experience in treating patients with metastatic breast cancer. They also need to be able to communicate in English and provide informed consent to take part in the interviews. Participants can expect to share their thoughts and experiences regarding the prognostic tool in a supportive environment, and their insights will play an important role in enhancing its usability for better patient care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Verbal informed consent obtained to participate in the study.
• • 2. Subject is willing and able to comply with study procedures based on the judgement of the investigator or protocol designee.
• • 3. Physician, nurse practitioner, physician assistant, or nurse navigator
• • 4. At least 6 months of experience in the clinical care of patients with metastatic breast cancer in the United States.
• Exclusion Criteria:
• • Non-English Speaking